Sutro Biopharma Inc's Customers Performance

Name: Sutro Biopharma Inc Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

STRO

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


STRO's Source of Revenues		During the corresponding time, Sutro Biopharma Inc saw a revenue deteriorated by -84.57 % year on year, sequentially revenue fell by -32.25 %. While revenue at the Sutro Biopharma Inc 's corporate clients • List of STRO Customers

for the same period Sutro Biopharma Inc revnue deteriorated by -84.57 % year on year, sequentially revenue fell by -32.25 %.

• List of STRO Customers

Sutro Biopharma Inc's Business Units


Ongoing Performance Related to Unsatisfied Performance Obligations	163.99 %	of total Revenue
Collaboration and License Agreements and Supply Agreements Vaxcyte Inc	1.58 %	of total Revenue
Astellas License and Collaboration Agreement Materials Supply	14.5 %	of total Revenue
Member	247.61 %	of total Revenue

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Sutro Biopharma Inc's Comment on Sales, Marketing and Customers

The company operates within legal and regulatory frameworks concerning healthcare fraud and abuse, privacy and security of health information, and data privacy laws. Relevant regulations include the Affordable Care Act (ACA), the Health Insurance Portability and Accountability Act (HIPAA), the Health Information Technology for Economic and Clinical Health Act (HITECH), the California Consumer Privacy Act (CCPA), the California Privacy Rights Act (CPRA), and state laws in California, Virginia, and Colorado.

Sutro Biopharma Inc’s Comment on Sales, Marketing and Customers

STRO's Stock Performance relative to it's Customers

STRO's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Sutro Biopharma Inc	332.59	99.61	-153.60	137
SUBTOTAL	0.00	0.00	0.00	-

Sources: Sutro Biopharma Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Sutro Biopharma Inc’s corporate clients.
For your research, we’ve provided 9 tables on Sutro Biopharma Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.